Surbhi Singhal, MD

This segment focuses on how clinicians decide between tissue biopsy and blood based testing when planning initial genomic evaluation.

This opening segment introduces the goals of the OncLive Insights program and frames genomic testing as a core element of the modern lung cancer diagnostic pathway.